Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP

Glycoconjugate Journal

Volumn 20, Issue 3, 2003, Pages 157-168

  Basu, Subhash ^a   Ma, Rui ^a   Mikulla, Brian ^a   Bradley, Mathew ^a   Moulton, Christopher ^a   Basu, Manju ^a   Banerjee, Sipra ^b   Inokuchi, Jin Ichi ^c  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYL 2 HEXADECANOYLAMINO 3 MORPHOLINO 1 PROPANOL; 2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; ANTINEOPLASTIC AGENT; CASPASE 3; CERAMIDE; GANGLIOSIDE; GLYCOLIPID; GLYCOSPHINGOLIPID; GLYCOSYLTRANSFERASE INHIBITOR; PROPANOL; RADIOACTIVE ELEMENT; SERINE; SYNTHETASE; TRITIUM; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST ADENOCARCINOMA; CANCER CELL; CARCINOMA CELL; CELL CULTURE; CELL GROWTH; CELL LINE; COLON CARCINOMA; CONCENTRATION (PARAMETERS); DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; ISOMER; LIPOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOISOMERISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBON RADIOISOTOPES; CASPASE 3; CASPASES; CELL LINE, TUMOR; CERAMIDES; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOSPHINGOLIPIDS; HUMANS; MEPERIDINE; MOLECULAR STRUCTURE; MORPHOLINES; NEOPLASMS; SERINE; STEREOISOMERISM;

TRITIUM;

EID: 3543110881     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:GLYC.0000024254.64450.8b     Document Type: Article

References (116)

1. Wyllie AH, Apoptosis, cell death in tissue regulation, J Pathol 153, 313-6 (1987).
2. Arends MJ, Wyllie AH, Apoptosis: Mechanisms and roles in pathology, Int Rev Exp Pathol 32, 223-54 (1991).
3. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong HH, Kinghom AD, Brown DM, et al., Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis, Nat Med 1, 1046-51 (1995).
4. Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC, Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells, Mol Pharmacol 46, 605-11 (1994).
5. Schmidt ML, Kuzmanoff KL, Ling-Indeck L, Pezzuto JM, Betulinic acid induces apoptosis in human neuroblastoma cell lines, Eur J Cancer 33, 2007-10 (1997).
6. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH, Law RE, Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines, FEBS Lett 345, 43-6 (1994).
7. Issandou M, Faucher C, Bayard F, Darbon JM, Opposite effects of tamoxifen on in vitro protein kinase C activity and endogenous protein phosphorylation in intact MCF-7 cells, Cancer Res 50, 5845-50 (1990).
8. Rohlff C, Blagosklonny MV, Kyle E, Kesari A, Kim IY, Zelner DJ, Hakim F, Trepel J, Bergan RC, Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and induction of p21(waf1/cip1), Prostate 37, 51-9 (1998).
9. Gundimeda U, Chen ZH, Gopalakrishna R, Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells, J Biol Chem 271, 13504-14 (1996).
10. Wajant H, The Fas signaling pathway: More than a paradigm, Science 296, 1635-6 (2002).
11. Neves SR, Ram PT, Iyengar R, G protein pathways, Science 296, 1636-9 (2002).
12. Singer AE, Koretzky GA, Control of T cell function by positive and negative regulators, Science 296, 1639-40 (2002).
13. Gauld SB, Dal Porto JM, Cambier JC, B cell antigen receptor signaling: Roles in cell development and disease, Science 296, 1641-2 (2002).
14. Moon RT, Bowerman B, Boutros M, Perrimon N, The promise and perils of Wnt signaling through beta-catenin, Science 296, 1644-6 (2002).
15. Attisano L, Wrana JL, Signal transduction by the TGF-beta superfamily, Science 296, 1646-7 (2002).
16. Vaudry D, Stork PJ, Lazarovici P, Eiden LE, Signaling pathways for PC12 cell differentiation: Making the right connections, Science 296, 1648-9 (2002).
17. Cantley LC, The phosphoinositide 3-kinase pathway, Science 296, 1655-7 (2002).
18. Parent CA, Devreotes PN, A cell's sense of direction, Science 284, 765-70 (1999).
19. Artavanis-Tsakonas S, Rand MD, Lake RJ, Notch signaling: Cell fate control and signal integration in development, Science 284, 770-6 (1999).
20. Burgering BM, Kops GJ, Cell cycle and death control: Long live Forkheads, Trends Biochem Sci 27, 352-60 (2002).
21. Ashkenazi A, Dixit VM, Death receptors, signaling and modulation, Science 281, 1305-8 (1998).
22. Devita VT, Hellman S, Rosenberg SA, Biologic Therapy of Cancer, 2nd edition (1995).
23. Kolesnick R, The therapeutic potential of modulating the ceramide/sphingomyelin pathway, J Cklin Invest 110, 3-8 (2002).
24. Kolesnick RN, Sphingomyelin and derivatives as cellular signals, Prog Lipid Res 30, 1-38 (1991).
25. Okazaki T, Bell RM, Hannun YA, Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation, J Biol Chem 264, 19076-80 (1989).
26. Okazaki T, Bielawska A, Bell RM, Hannun YA, Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation, J Biol Chem 265, 15823-31 (1990).
27. Hannun YA, Luberto C, Argraves KM, Enzymes of sphingolipid metabolism: From modular to integrative signaling, Biochemistry 40, 4893-903 (2001).
28. Hakomori S, Tumor-associated carbohydrate antigens, Annu Rev Immunol 2, 103-26 (1984).
29. Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E, Hakomori S, Characterization of sialosylated Lewisx as a new tumor-associated antigen, Cancer Res 44, 5279-85 (1984).
30. x, Science 250, 1130-32 (1990).
31. Hakomori S, Handa K, Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: Essential basis to define tumor malignancy, FEBS Lett 531, 88-92 (2002).
32. Hakomori S, Glycosylation defining cancer malignancy: New wine in an old bottle, Proc Natl Acad Sci USA 99, 10231-3 (2002).
33. Ugorski M, Laskowska A, Sialyl Lewis(a): A tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells, Acta Biochim Pol 49, 303-11 (2002).
34. Fuster MM, Brown JR, Wang L, Esko JD, A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells, Cancer Res 63, 2775-81 (2003).
35. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R, Ceramide synthase mediates daunombicin-induced apoptosis: An alternative mechanism for genera ting death signals, Cell 82, 405-14 (1995).
36. Liao WC, Haimovitz-Friedman A, Persaud RS, McLoughlin M, Ehleiter D, Zhang N, Gatei M, Lavin M, Kolesnick R, Fuks Z, Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase, J Biol Chem 274, 17908-17 (1999).
37. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S, Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate, Nature 381, 800-3 (1996).
38. Pettus BJ, Chalfant CE, Hannun YA, Ceramide in apoptosis: An overview and current perspectives, Biochim Biophys Acta 1585, 114-25 (2002).
39. Tilly JL, Kolesnick RN, Sphingolipids, apoptosis, cancer treatments and the ovary: Investigating a crime against female fertility, Biochim Biophys Acta 1585, 135-8 (2002).
40. Cuvillier O, Sphingosine in apoptosis signaling, Biochim Biophys Acta 1585, 153-62 (2002).
41. Radin NS, Killing tumours by ceramide-induced apoptosis: A critique of available drugs, Biochem J 371, 243-56 (2003).
42. Bieberich E, Hu B, Silva J, MacKinnon S, Yu RK, Fillmore H, Broaddus WC, Ottenbrite RM, Synthesis and characterization of novel ceramide analogs for induction of apoptosis in human cancer cells, Cancer Lett 181, 55-64 (2002).
43. Goswami R, Kilkus J, Scurlock B, Dawson G, CrmA protects against apoptosis and ceramide formation in PC12 cells, Neurochem Res 27, 735-41 (2002).
44. Luberto C, Kraveka JM, Hannun YA, Ceramide regulation of apoptosis versus differentiation: A walk on a fine line. Lessons from neurobiology, Neurochem Res 27, 609-17 (2002).
45. Toman RE, Movsesyan V, Murthy SK, Milstien S, Spiegel S, Faden AI, Ceramide-induced cell death in primary neuronal cultures: Upregulation of ceramide levels during neuronal apoptosis, J Neurosci Res 68, 323-30 (2002).
46. Akao Y, Kusakabe S, Banno Y, Kito M, Nakagawa Y, Tamiya-Koizumi K, Hattori M, Sawada M, Hirabayasi Y, Ohishi N, Nozawa Y, Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells, Biochem Biophys Res Commun 294, 363-70 (2002).
47. el Bawab S, Mao C, Obeid LM, Hannun YA, Ceramidases in the regulation of ceramide levels and function, Subcell Biochem 36, 187-205 (2002).
48. Jaffrezou JP, Laurent G, Levade T, Ceramide in regulation of apoptosis. Implication in multitoxicant resistance, Subcell Biochem 36, 269-84 (2002).
49. Ahn EH, Schroeder JJ, Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells, Exp Biol Med (Maywood) 227, 345-53 (2002).
50. Smyth MJ, Obeid LM, Hannun YA, Ceramide: A novel lipid mediator of apoptosis, Adv Pharmacol 41, 133-54 (1997).
51. Hannun YA, Obeid LM, Mechanisms of ceramide-mediated apoptosis, Adv Exp Med Biol 407, 145-9 (1997).
52. Kolesnick RN, Kronke M, Regulation of ceramide production and apoptosis, Annu Rev Physiol 60, 643-65 (1998).
53. Colell A, Morales A, Fernandez-Checa JC, Garcia-Ruiz C, Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-alpha-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3, FEBS Lett 526, 135-41 (2002).
54. Malisan F, Testi R, GD3 in cellular ageing and apoptosis, Exp Gerontol 37, 1273-82 (2002).
55. Paris R, Morales A, Coll O, Sanchez-Reyes A, Garcia-Ruiz C, Fernandez-Checa JC, Ganglioside GD3 sensitizes human hepatoma cells to cancer therapy, J Biol Chem 277, 49870-6 (2002).
56. Watanabe R, Ohyama C, Aoki H, Takahashi T, Satoh M, Saito S, Hoshi S, Ishii A, Saito M, Arai Y, Ganglioside GM3 overexpression induces apoptosis and reduces malignant potential in murine bladder cancer, Cancer Res 62, 3850-4 (2002).
57. Simon BM, Malisan F, Testi R, Nicotera P, Leist M, Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis, Cell Death Differ 9, 758-67 (2002).
58. Copani A, Melchiorri D, Caricasole A, Martini F, Sale P, Carnevale R, Gradini R, Sortino MA, Lenti L, De Maria R, Nicoletti F, Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons, J Neurosci 22, 3963-8 (2002).
59. Kristal BS, Brown AM, Apoptogenic ganglioside GD3 directly induces the mitochondrial permeability transition, J Biol Chem 274, 23169-75 (1999).
60. Scorrano L, Petronilli V, Di Lisa F, Bernardi P, Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore, J Biol Chem 274, 22581-5 (1999).
61. Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G, Testi R, GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion, Faseb J 14, 2047-54 (2000).
62. Kristal BS, Brown AM, Ganglioside GD3, the mitochondrial permeability transition, and apoptosis, Ann NY Acad Sci 893, 321-4 (1999).
63. Kannagi R, Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer, Glycoconj J 14, 577-84 (1997).
64. Farmer RW, Richtsmeier WJ, Scher RL, Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck, Head Neck 20, 726-31 (1998).
65. Ugorski M, Laskowska A, Sialyl lewis a: A tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells, Acta Biochimica 49, 303-11 (2002)
66. Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Kurosaki N, Ayabe H, Arisawa K, Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer, Cancer Detect Prev 25, 299-308 (2001).
67. Paganuzzi M, Bobbio B, Marroni P, Filiberti R, Secco GB, Grossi CE, Prognostic role of serum sialyl Lewisx (CD15s) in colorectal cancer, Oncology 65, 52-9 (2003).
68. Renkonen J, Paavonen T, Renkonen R, Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma, Int J Cancer 74, 296-300 (1997).
69. O I, Otvos L, Kieber-Emmons T, Blaszczyk-Thurin M, Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist, Peptides 23, 999-1010 (2002).
70. x by alpha 1-3 fucosyltransferases from colon carcinoma cells and embryonic brain tissues, Glycobiology 1, 527-35 (1991).
71. Basu M, Basu SS, Li Z, Tang H, Basu S, Biosynthesis and regulation of Le(x) and SA-Le(x) glycolipids in metastatic human colon carcinoma cells, Indian J Biochem Biophys 30, 324-32 (1993).
72. Basu M, Khan FA, Das KK, Zhang BJ, Biosynthesis in vitro of core lacto-series glycosphingolipids by N-acetyl-D-glucosaminyltransferases from human colon carcinoma cells, Colo 205, Carbohydr Res 209, 261-77 (1991).
73. Basu SS, Basu M, Li Z, Basu S, Characterization of two glycolipid: Alpha 2-3sialyltransferases, SAT-3 (CMP-NeuAc:nLcOse4Cer alpha 2-3sialyltransferase) and SAT-4 (CMP-NeuAc:GgOse4Cer alpha 2-3sialyltransferase), from human colon carcinoma (Colo 205) cell line, Biochemistry 35, 5166-74 (1996).
74. Basu SS, Basu M, Dastgheib S, Ghosh S, Basu S, Cloning and expression of SAT-3 involved in SA-Le(x) biosynthesis: Inhibition studies with polyclonal antibody against GST-SAT-3 fusion protein, Indian J Biochem Biophys 34, 97-104 (1997).
75. Basu S, Basu M, Dastgheib S, Haws JW, Biosynthesis and regula-tion of glycosphingolipids. In Comprehensive Natural Products Chemistry, edited by Barton D, Nakanishi K, Meth-Cohen O, Pinto BM (Pergamon Press, New York, 1999), Vol. 3, pp. 107-128.
76. Basu S, Das, K, Basu M, Glycosyltransferase in oligosaccharides in chemistry and biology - A comprehensive handbook, Glycosyltransferases in Glycosphingolipid Biosynthesis, edited by Ernst B, Sinay P, Hart G (Wiley-VCH Verlag GmbH, Germany, 2000), pp. 329-347.
77. x determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells, J Biol Chem 261, 3737-43 (1986).
78. y) determinants in human blood cell membranes (ghosts). Evidence that type 2 chain can elongate repetitively but type 1 chain cannot, J Biol Chem 260, 6410-5 (1985).
79. Kaufman B, Basu S, Roseman S, Isolation of glucosylceramides from yeast (Hansenula ciferri), J Biol Chem 246, 4266-71 (1971).
80. Dickson RC, Lester RL, Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae, Biochim Biophys Acta 1438, 305-21 (1999).
81. Ohashi Y, Tanaka T, Akashi S, Morimoto S, Kishimoto Y, Nagai Y, Squid nerve sphingo-myelin containing an unusual sphingoid base, J Lipid Res 41, 1118-24 (2000).
82. Carter HL, Hendry RA, Mojima S, Stanacer NF, Biochim Biophys Acta 45 402-16 (1960)
83. Lester RL, Dickson RC, Sphingolipids with inositolphosphate-containing head groups, Adv Lipid Res 26, 253-74 (1993).
84. Sperling P, Heinz L, Plant sphingolipids: Structural diversity, biosynthesis, first genes and functions, Biochim Biophys Acta 1632, 1-15 (2003).
85. Basu S, Ma R, Mikulla B, Boyle P, Basu M, Bose R, Apoptosis of human colon and breast carcinoma cells by inhibitors of DNA, Glycolipid and Glycoprotein biosynthesis. Proceedings of FASEB Summer Research Meeting on "Apoptosis and Immunity" (July 13-18 2002), p. 9.
86. Basu S, Ma R, Milulla B, Boyle P, Basu M, Bose R, Apoptosis of human colon and breast carcinoma cells by inhibitors of glycoconjugate biosynthesis. In Proceedings of XVIIth International Meeting on Glycoconjugate in Bangalore, India (Jan. 11-15, 2003), p. 42.
87. Basu S, Ma R, Milulla B, Boyle P, Moulton C, Campbell B, Basu M, Bose R, Role of cancer cell surface glycoconjugate in the anti-cancer drug discorvery. In Proceedings of 6th International Cell Surface Meeting in Kolkata, India. (Jan. 16-18, 2003), p. 1.
88. Ma R, Daus B, Hesketh A, Galindo E, Basu M, Banerjee S, Basu S, Apoptosis induction in colon (Colo-205) and breast (SKBr3) carcinoma cells by L-PPMP and regulation of gene expression of a glycolipid:glycosyltransferase. Cell Biol. Abstract-, vol. (2003).
89. Basu S, Kaufman B, Roseman S, Enzymatic synthesis of glucocerebroside by a glucosyltransferase from embryonic chicken brain, J Biol Chem 248, 1388-94 (1973).
90. Basu M, Basu S, Enzymatic synthesis of a tetraglycosylceramide by a galactosyltransferase from rabbit bone marrow, J Biol Chem 247, 1489-95 (1972).
91. Basu M, Basu S, Enzymatic synthesis of a blood group B-related pentaglycosylceramide by an alpha-galactosyltransferase from rabbit bone marrow, J Biol Chem 248, 1700-6 (1973).
92. Basu M, De T, Das KK, Kyle JW, Chon HC, Schaeper RJ, Basu S. Glycosyltransferases involved in glycolipid biosynthesis. Methods in Enzymol. edited by Ginsburg V. vol. 138 (Academic Press, New York, 1987) pp. 575-607.
93. Narimatsu H, Sinha S, Brew K, Okayama H, Qasba PK, Cloning and sequencing of cDNA of bovine N-acetylglucosamine (beta 1-4)galactosyltransferase, Proc Natl Acad Sci USA 83, 4720-4 (1986).
94. Shaper NL, Shaper JH, Meuth JL, Fox JL, Chang H, Kirsch IR, Hollis GF, Bovine galactosyltransferase: Identification of a clone by direct immunological screening of a cDNA expression library, Proc Natl Acad Sci USA 83, 1573-7 (1986).
95. Ghosh S, Basu SS, Basu S, Isolation of acDNA clone for beta 1-4-galactosyltransferase from embryonic chicken brain and comparison to its mammalian homologs, Biochem Biophys Res Commun 189, 1215-22 (1992).
96. Basu SS, Dastgheib S, Ghosh S, Basu M, Kelly P, Basu S, Purification and characterization of avian glycolipid: Beta-galactosyltransferases (GalT-4 and GalT-3): Cloning and expression of truncated betaGalT-4, Acta Biochim Pol 45, 451-67 (1998).
97. Basu M, Basu S, Stoffyn A, Stoffyn P, Biosynthesis in vitro of sialyl(alpha2-3)neolactotetraosylceramide by a sialyltransferase from embryonic chicken brain, J Biol Chem 257, 12765-9 (1982).
98. Kitagawa H, Mattei MG, Paulson JC, Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2,3- sialyltransferase, J Biol Chem 271, 931-8 (1996).
99. Lee YC, Kojima N, Wada E, Kurosawa N, Nakaoka T, Hamamoto T, Tsuji S, Cloning and expression of cDNA for a new type of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase, J Biol Chem 269, 10028-33 (1994).
100. Radin NS, Chemotherapy by slowing glucosphingolipid synthesis, Biochem Pharmacol 57, 589-95 (1999).
101. Manning LS, Radin NS, Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells, Br J Cancer 81, 952-8 (1999).
102. Eldadah BA, Yakovlav AG, Faden AL, A new approach for the electrophoretic detection of apoptosis, Nucleic Acids Res 24, 4092-3 (1996).
103. Gullicksen PS, Dean RG, Baile CA., Detection of DNA fragments and apoptotic proteins and quantification of uncoupling protein expression by real-time RT-PCR in adipose tissue, J Biochem Biophgys Methods 58, 1-13 (2004).
104. Thornberry NA, Lazebnik Y, Caspases: Enemies within, Science 281, 1312-6 (1998).
105. Green DR, Reed JC, Mitochondria and apoptosis, Science 281, 1309-12 (1998).
106. Wang L, Ma R, Flavell RA, Choi ME, Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells, J Biol Chem 277, 47257-62 (2002).
107. Koulov AV, Stucker KA, Lakshmi C, Robinson JP, Smith BD, Detection of apoptotic cells using a synthetic fluorescent sensor for membrane surfaces that contain phosphatidylserine, Cell Death Differ 10, 1357-9 (2003).
108. Peterson GL, A simplification of the protein assay method of Lowry et al. which is more generally applicable, Anal Biochem 83, 346-56 (1977).
109. Das KK, Basu M, Basu S, A rapid preparative method for isolation of neutral and acidic glycosphingolipids by radial thin layer chromatography, Anal Biochem 125-134 (1984).
110. Jenis DM, Basu S. Pollard M. Increased activity of a b- galactosyltransferase in tissues of rats bearing prostate and mammary adenocarcinomas, Cancer Biochem Biophys 6, 37-45 (1982).
111. Wang AM, Doyle MV, Mark DF, Quantification of mRNA by the polymerase chain reaction, Proc Natl Acad Sci USA 86, 9717-21 (1989).
112. Taniguchi N., Honke K, Fukuda M, Handbook of Glycosyltransferases and their Related Genes (Springer, Tokyo, 2002).
113. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T, Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression, Proc Natl Acad Sci USA 99, 10718-23 (2002).
114. Yates AJ, Ramprosad A, in Sphingolipids as Signaling Modulators in the Nervous System, edited by Ledeen RW, Hakomori S, Yates AJ, Schneider JS, Yu RK (Ann. N.Y. Acad. Sci., New York, 1998), Vol. 845. pp. 57-71.
115. Hiraishi K, Suzuki K, Hakomori S, Adachi M, Le(y) antigen expression is correlated with apoptosis (programmed cell death), Glycobiology 3, 381-90 (1993).
116. Zeng G, Gao L, Birkle S, Yu RK, Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production, Cancer Res 60, 6670-6 (2000).